# BioAccess, Inc. – FDA Inspection, Aug 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/bioaccess-inc/1163c5a4-4acc-41bc-9c82-ce0676d966ea
Source feed: FDA_Inspections

> FDA inspection 1246993 of BioAccess, Inc., August 20, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 820. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246993
- Company Name: BioAccess, Inc.
- Inspection Date: 2024-08-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1267578 - 2025-04-22](https://www.keypedia.com/records/fda_inspections/bioaccess-inc/e9bb63b6-e4c4-4600-8c13-15fa98f9afdf)
- FDA Inspection 993631 - 2016-11-17
- FDA Inspection 656896 - 2010-04-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nisha-c-patel/1b38764f-c7bc-4f90-9af1-54989ad6d59c)

Company: https://www.keypedia.com/companies/bioaccess-inc/68cc8373-100b-41eb-9af7-c8b60bc037f4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
